Biocon arm gets USFDA nod for chronic heart failure drug

Biocon Pharma, a wholly owned subsidiary of Biocon, has received approval of its ANDA for Sacubitril/Valsartan Tablets, from the U.S Food and Drug Administration (US FDA).